Dengvaxia

Indicated For

dengue fever prevention

About This Medication

# Sanofi Patient Connection Patient Guide: How to Get Dengvaxia at Low or No Cost Dengvaxia (CYD-TDV) is a dengue vaccine made by Sanofi to help prevent dengue disease in people aged 9 to 45 who live in areas with high dengue risk and have had dengue before. This guide explains the **Sanofi Patient Connection** program, which provides Dengvaxia at no cost to eligible U.S. patients who can't afford it.[1][7] ## About Dengvaxia **Dengvaxia** is the only FDA-approved vaccine for preventing dengue fever caused by all four dengue virus serotypes (1, 2, 3, and 4). It's for individuals 9 through 45 years old who have lab-confirmed prior dengue infection and live in endemic areas like Puerto Rico, U.S. Virgin Islands, or American Samoa.[10][4] The vaccine works best in people previously exposed to dengue, following a 'screen and vaccinate' approach recommended by the WHO and ACIP.[4] It's given as three doses over 12 months. Always talk to your doctor about if it's right for you—it's not for everyone, especially those never infected with dengue, as it may increase risks.[9][10] ## Who Qualifies for Sanofi Patient Connection? Sanofi Patient Connection helps U.S. residents get free Sanofi medications, including vaccines like Dengvaxia if listed or eligible under their programs.[1][5][7] Key requirements: - **U.S. residency**: You must live in the U.S. or U.S. Territories (e.g., Puerto Rico) and be under a licensed U.S. healthcare provider (HCP).[1][7] - **Income limits**: Household income at or below **400% of the Federal Poverty Level (FPL)**.[1][7] - **Insurance**: For commercial insurance, no coverage for the vaccine; government programs like Medicaid require denial proof.[1][7] - **Prescription**: Valid prescription from your HCP.[7] This program is part of Sanofi Cares North America and targets uninsured or underinsured patients.[1] ## Income Eligibility Breakdown Eligibility is based on **annual household income ≤400% FPL**. Use the table below for 2025 guidelines (adjust for current year via HHS.gov; examples for continental U.S.): | Household Size | 100% FPL | 400% FPL (Max Eligible) | |----------------|----------|-------------------------| | 1 person | $15,060 | **$60,240** | | 2 people | $20,440 | **$81,760** | | 3 people | $25,820 | **$103,280** | | 4 people | $31,200 | **$124,800** | | +1 person | +$5,380 | **+$21,520** | *Notes: Alaska/Hawaii have higher limits. Provide proof like tax returns. Medicaid applicants need denial letter.*[1] ## Insurance Requirements - **No coverage needed**: Ideal for uninsured patients.[1] - **Commercial insurance**: Must show denial of coverage for Dengvaxia.[1] - **Medicaid/Medicare**: Submit denial documentation; program assesses after.[1][7] - Sanofi support specialists can help check coverage at 888-847-4877.[2] ## Step-by-Step Application Process 1. **Get screened and prescribed**: Confirm prior dengue infection via lab test; get prescription from HCP.[4][10] 2. **Download application**: Visit sanofipatientconnection.com, select your state, download PDF.[3][7] 3. **Fill out form**: Page 2—patient info, sign HIPAA/income consent. HCP completes their section.[7] 4. **Gather documents**: Proof of income (tax return, pay stubs, W-2s), residency, insurance denial if applicable, prescription.[7] 5. **Submit**: Mail to Sanofi Patient Connection, PO Box 222138, Charlotte, NC 28222-2138 or fax 1-888-847-1797.[7] 6. **Call for help**: 888-847-4877 for questions.[2] No fees for application; third-party fees not required.[7] ## Timeline and Delivery - **Review**: After receipt, Sanofi reviews eligibility.[7] - **Approval**: If eligible, HCP gets notification; vaccine ships to **HCP's office in 5-7 business days**.[7] - **Denial**: Letter explains why; explore alternatives.[7] Processing aims for quick turnaround; call for status.[2] ## Alternatives if Denied - **Reimbursement Connection**: Help with insurance copays via Sanofi Patient Connection.[8] - **Resource Connection**: Find other aid, state programs.[1][8] - **Temporary Access**: Short-term supply.[1] - **Vaccine programs**: Check Vaccines for Children (VFC) if eligible, or local health departments in dengue-endemic areas.[10] - **Appeal or reapply**: Fix issues and resubmit.[7] - No biosimilars for Dengvaxia; it's unique.[4] ## Important Disclaimer This guide is for informational purposes based on available program details as of latest info. Eligibility, availability for Dengvaxia specifically—not explicitly listed—confirm with Sanofi at 888-847-4877 or sanofipatientconnection.com. Rules change; not medical/financial advice. Consult your doctor/HCP. Sanofi not liable for application errors. Program offers free meds where eligible but no guarantees.[1][7] (Word count: 942)

Program information last verified: March 30, 2026